Symbol="MYGN"
AssetType="Common Stock"
Name="Myriad Genetics Inc"
Description="Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized, and prognostic medicine tests in the United States and internationally. The company is headquartered in Salt Lake City, Utah."
CIK="899923"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES"
Address="320 WAKARA WAY, SALT LAKE CITY, UT, US"
FiscalYearEnd="June"
LatestQuarter="2023-06-30"
MarketCapitalization="1361156000"
EBITDA="-119900000"
PERatio="None"
PEGRatio="1.11"
BookValue="8.98"
DividendPerShare="0"
DividendYield="0"
EPS="-1.8"
RevenuePerShareTTM="8.61"
ProfitMargin="-0.355"
OperatingMarginTTM="-0.257"
ReturnOnAssetsTTM="-0.0935"
ReturnOnEquityTTM="-0.295"
RevenueTTM="698900000"
GrossProfitTTM="476400000"
DilutedEPSTTM="-1.8"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.023"
AnalystTargetPrice="21.72"
TrailingPE="-"
ForwardPE="40.98"
PriceToSalesRatioTTM="2.15"
PriceToBookRatio="1.666"
EVToRevenue="2.224"
EVToEBITDA="-19.13"
Beta="1.775"
num_52WeekHigh="27.92"
num_52WeekLow="13.92"
num_50DayMovingAverage="22.15"
num_200DayMovingAverage="20.48"
SharesOutstanding="81555000"
DividendDate="None"
ExDividendDate="None"
symbol="MYGN"
open="16.62"
high="17.92"
low="16.48"
price="17.89"
volume="616567.00"
latest_trading_day="2023-08-11"
previous_close="16.69"
change="1.20"
change_percent="7.1899%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="27"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="73"
Volume_recent_avg="529804"
Change_recent_avg="-0.04"
Delta_recent_avg="0.88"
Variance_recent_avg="0.44"
Change_ratio_recent_avg="-0.21"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="73"
Aroon_momentum_negative="27"
image_negative_thumbnail_id_1="1145"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0178.jpeg"
image_negative_thumbnail_id_2="97"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0079.jpeg"
image_neutral_thumbnail_id_1="536"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0063.jpeg"
image_neutral_thumbnail_id_2="564"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0035.jpeg"
image_positive_thumbnail_id_1="654"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0054.jpeg"
image_positive_thumbnail_id_2="663"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0045.jpeg"
image_professor_thumbnail_id_1="1180"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
